drugset / Trial / NCT02048683

A Pharmacokinetic Study of Sevoflurane Inhalation in Burn ICU Patients

NCT02048683

Phase 2 Completed 24 enrolled University Hospital, Clermont-Ferrand
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Comparing a pharmacokinetic model of a short sevoflurane sedation in burn ICU patients with control ICU patients.

Timeline

Start
2013-12
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sevoflurane Other / unclassified Inhaled

Indications

No indication recorded.